CNW/ - Sona Nanotech Inc., (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is pleased to announce its clinical strategy ...
Mastectomy did not significantly improve survival for younger women with high-risk locoregionally advanced breast cancer, ...
The FDA is looking at a slew of label expansions this month, including one that could open up home-based treatments for Alzheimer’s disease.
Investigators analyzed the immune-modulatory cancer vaccine IO102-IO103 plus pembrolizumab for PFS in patients with untreated advanced melanoma.
Neoadjuvant immunotherapy is emerging as a valuable option for patients with complex or borderline resectable cutaneous squamous cell carcinoma (CSCC). Administered before surgery, PD-1 inhibitors ...
Immunotherapy has become a standard of care in treating high-risk, early-stage breast cancers, yet it has had limited success ...
Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.
Barbara Burtness, MD, discusses the latest highlights from the AACR Annual Meeting 2026 that took place April 17-22.
Following IDMC recommendation after interim futility analysis the decision was made to discontinue the TACTI-004 Phase III trialRoot cause ...
Adding immunotherapy to neoadjuvant chemotherapy more than doubled mediastinal lymph node clearance rates compared with ...
Neoadjuvant immunotherapy is expanding treatment options in CSCC by shrinking complex tumors, improving surgical outcomes, ...
Gastroenteropancreatic neuroendocrine carcinoma (NEC) represents a challenging subset of extrapulmonary neuroendocrine tumors, predominantly originating in the gastrointestinal tract. These poorly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results